(Q37805788)

23 August 2017

title

The platelet contribution to cancer progression (English)

1 reference

23 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21040448

18 August 2024

author name string

N. M. Bambace

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21040448

18 August 2024

C. E. Holmes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21040448

18 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21040448

18 August 2024

publication date

1 February 2011

1 reference

full work available at URL

23 August 2017

http://www.jthjournal.org/article/S1538783622074955/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21040448

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1538-7836.2010.04131.x

18 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

https://api.elsevier.com/content/article/PII:S1538783622074955?httpAccept=text/xml

18 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

https://api.elsevier.com/content/article/PII:S1538783622074955?httpAccept=text/plain

18 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2010.04131.x/fullpdf

18 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Journal of Thrombosis and Haemostasis

18 August 2024

published in

1 reference

23 August 2017

volume

9

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

237-249

1 reference

Platelets and angiogenesis in malignancy.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet integrin alpha(IIb)beta(3): activation mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Activation of platelet function through G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Differing platelet aggregating effects by two tumor cell lines: Absence of role for platelet‐derived ADP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Abnormal haemostasis in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Contribution of the hemostatic system to angiogenesis in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Antimetastatic effects associated with platelet reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Role of platelets in tumor cell metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Poor prognosis associated with thrombocytosis in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Significance of thrombocytosis in patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Response of a human megakaryocytic cell line to thrombin: increase in intracellular free calcium and mitogen release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The effect of platelets on invasiveness and protease production of human mammary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Integrin activation controls metastasis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-mimicry of cancer cells: epiphenomenon with clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Central role of the P2Y12 receptor in platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Role of thrombin in angiogenesis and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tumor-cell-induced platelet aggregation is a glycoprotein-dependent and lipoxygenase-associated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inhibition of platelet GPIb alpha and promotion of melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet glycoprotein Ib alpha supports experimental lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

P-selectin deficiency attenuates tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Microparticles, thrombosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Modulation of monocyte-endothelial cell interactions by platelet microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Activated macrophages induce vascular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The hemostatic system and angiogenesis in malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tumors stimulate platelet delivery of angiogenic factors in vivo: an unexpected benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelets actively sequester angiogenesis regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Evidence that platelets promote tube formation by endothelial cells on matrigel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-endothelial interaction in tumor angiogenesis and microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

P2Y purinergic receptors regulate the growth of human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Thrombin generation and the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tissue factor and PAR2 signaling in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-associated PF-4 as a biomarker of early tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelets: guardians of tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet granule secretion continuously prevents intratumor hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Innate immune cells induce hemorrhage in tumors during thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inflammation induces hemorrhage in thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Placebo-controlled study on the efficacy of the pyrimido-pyrimidine derivative RA 233 in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Moderation of the platelet releasate response by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet—tumor-cell interactions in mice. The role of platelets in the spread of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Aspirin and non-small cell lung cancer resections: effect on long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Aspirin intake and survival after breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet and osteoclast β 3 integrins are critical for bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Release of gelatinase A during platelet activation mediates aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues

21 January 2018

9

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Increased thromboxane A2 production at primary tumor site in metastasizing squamous cell carcinoma of the larynx

18 August 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Studies on platelet function in patients with prostatic cancer. Preliminary report

18 August 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

beta-Thromboglobulin in patients with breast cancer

18 August 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Platelet activation and platelet lipid composition in pulmonary cancer

18 August 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Platelet Activation and Fibrinolysis in Large Bowel Cancer

18 August 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

[Platelet activation in thrombotic and prethrombotic venous pathology]

18 August 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Circulating activated platelets in myeloproliferative disorders

18 August 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Thrombocytosis as a prognostic factor in endometrial carcinoma

18 August 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival

18 August 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Thrombocytosis as a prognostic factor in women with cervical cancer

18 August 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer

18 August 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis

18 August 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Increased secretion of interleukin-6 in malignant mesothelioma cells from a patient with marked thrombocytosis

18 August 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Platelet contribution to cancer cell growth and migration: the role of platelet growth factors

18 August 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Malignant cell attachment to endothelium of ex vivo perfused human umbilical vein. Modulation by platelets, plasma and fibronectin

18 August 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Sequence of events in experimental metastases of Walker 256 tumor: light, immunofluorescent, and electron microscopic observations

18 August 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Platelet: transporter of vascular endothelial growth factor

18 August 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Evidence for an alpha-granular pool of the cytoskeletal protein alpha-actinin in human platelets that redistributes with the adhesive glycoprotein thrombospondin-1 during the exocytotic process

18 August 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Platelet alpha-granule proteins: studies on release and subcellular localization

18 August 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

18 August 2024

Pulmonary microembolism

65

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets

18 August 2024

68

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo

18 August 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Tumor cell procoagulant and urokinase expression in carcinoma of the ovary

18 August 2024

74

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ

18 August 2024

75

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface

18 August 2024

76

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Cancer procoagulant stimulates platelet adhesion

18 August 2024

80

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin

18 August 2024

81

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Inhibition of human tumor cell induced platelet aggregation by antibodies to platelet glycoproteins Ib and IIb/IIIa

18 August 2024

86

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis

18 August 2024

90

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization

18 August 2024

106

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Involvement of platelets in tumour angiogenesis?

18 August 2024

109

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Tumor induction of VEGF promoter activity in stromal cells

18 August 2024

112

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Normal ranges of angiogenesis regulatory proteins in human platelets

18 August 2024

117

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

The functional role of blood platelet components in angiogenesis

18 August 2024

129

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Chemotherapy plus RA233 in the treatment of oat cell lung cancer

18 August 2024

150

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma

18 August 2024

151

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Inhibition of metastases by anticoagulants

18 August 2024

158

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.

18 August 2024

166

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomized clinical trial of 303 patients. The "Petites Cellules" Group

18 August 2024

170

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

Use of inhibitors of prostaglandin synthesis in patients with breast cancer

18 August 2024

173

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

High-dose cisplatin with dipyridamole in advanced non-small cell lung cancer. A Grupo Oncológico Cooperativo del Sur study

18 August 2024

175

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04131.X

18 August 2024

Identifiers

1 reference

23 August 2017

1 reference